Recent Finacing
Recent Raise
Neovacs develops therapeutic vaccines using Kinoid technology to induce polyclonal anti‑cytokine responses, advancing IFNα‑Kinoïde in lupus/dermatomyositis clinical trials, scaling manufacturing and building a Paris production site.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor